---
title: "Jefferies Keeps Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292077553.md"
description: "Jefferies analyst Roger Song maintained a Buy rating on Kailera Therapeutics (KLRA) with a $48 price target. This follows TD Cowen's recent decision to also keep a Buy rating on the stock, setting a higher target of $57. Both firms express positive sentiment towards the healthcare company."
datetime: "2026-07-08T13:35:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292077553.md)
  - [en](https://longbridge.com/en/news/292077553.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292077553.md)
generator: "portal-rs"
---

# Jefferies Keeps Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)

In a report released today, Roger Song from Jefferies maintained a Buy rating on Kailera Therapeutics, Inc., with a price target of $48.00.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Song covers the Healthcare sector, focusing on stocks such as Nurix Therapeutics, Kailera Therapeutics, Inc., and TG Therapeutics. According to TipRanks, Song has an average return of 4.5% and a 43.68% success rate on recommended stocks. 

In a report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $57.00 price target.

### Related Stocks

- [KLRA.US](https://longbridge.com/en/quote/KLRA.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [NRIX.US](https://longbridge.com/en/quote/NRIX.US.md)
- [TGTX.US](https://longbridge.com/en/quote/TGTX.US.md)

## Related News & Research

- [Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)](https://longbridge.com/en/news/296645903.md)
- [Jefferies Sticks to Its Buy Rating for Covista (CVSA)](https://longbridge.com/en/news/296118987.md)
- [Piper Sandler Reaffirms Their Buy Rating on Akebia Therapeutics (AKBA)](https://longbridge.com/en/news/296105482.md)
- [Berenberg Bank Sticks to Their Buy Rating for SAFRAN SA (0IU8)](https://longbridge.com/en/news/296197156.md)
- [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**